Many cancers that affect Black patients receive less research funding, as do some cancers that have high mortality rates.
A retrospective, single-institution cohort study investigated the effect of prior PARP inhibitors and subsequent progression-free survival in platinum-sensitive ovarian cancer.
The Cleveland Clinic Center for Research Excellence in Gynecologic Cancer (CREGC) is a collaborative network for the development of a comprehensive research program to promote the translation of basic science investigation into the clinic.
Primary care physicians and Ob/Gyn providers are on the front lines of gynecologic cancer detection and have an important role in screening compliance, patient education, early detection and quick referral.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Gynecologic oncologists deliver radiation using sophisticated computerized imaging guidance systems and robotics to treat cancers once considered unbeatable.
Hyperthermic intraperitoneal chemotherapy, which involves the intraoperative delivery and circulation of heated cancer drugs, is showing promise for cancers of the peritoneal cavity arising from gynecologic cancers. The technique is a welcome development in the treatment of a disease whose outcome has changed little in the past two decades.